Description

3-Bromo-2-Dichloromethyl-7-Methyl-Imidazo[1,2-A]Pyridine Hydrobromide is a high-purity, advanced pharmaceutical intermediate crucial for modern drug discovery and development. This compound matters because it serves as a sophisticated building block for synthesizing novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex heterocyclic scaffolds. Pharmaceutical R&D teams and fine chemical manufacturers need this material for creating next-generation medications targeting a range of diseases.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel Active Pharmaceutical Ingredients (APIs) for preclinical and clinical research.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new drug candidates.
• Heterocyclic Compound Synthesis: Serves as a versatile precursor for constructing complex fused-ring systems in organic synthesis.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up of complex molecules.
• Academic Research: Utilized in university and institutional labs for methodological development and chemical biology studies.
• Agrochemical Intermediate: Potential application in the development of new crop protection agents with specific biological activity.

Basic Information

Product Name	3-Bromo-2-Dichloromethyl-7-Methyl-Imidazo[1,2-A]Pyridine Hydrobromide
CAS No.	1332606-31-1
Molecular Formula	C10H8BrCl2N2 • HBr
Molecular Weight	Contact for details
Synonyms	3-Bromo-2-(dichloromethyl)-7-methylimidazo[1,2-a]pyridine hydrobromide; Imidazo[1,2-a]pyridine, 3-bromo-2-(dichloromethyl)-7-methyl-, hydrobromide; 3-Bromo-2-dichloromethyl-7-methylimidazo[1,2-a]pyridine HBr salt; CAS 1332606-31-1; 7-Methyl-3-bromo-2-dichloromethylimidazo[1,2-a]pyridine hydrobromide
EINECS	Contact for details

Quality Control

Our 3-Bromo-2-Dichloromethyl-7-Methyl-Imidazo[1,2-A]Pyridine Hydrobromide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) documenting all critical quality attributes are available upon request. We support compliance with cGMP and ICH Q7 guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept sealed under an inert atmosphere (e.g., nitrogen or argon) when not in use to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.